Drug Safety Laboratory, Drug Safety and Pharmacokinetics Laboratories, Taisho Pharmaceutical Co., Ltd., 403 Yoshino-cho 1, Kita-ku, Saitama-shi, Saitama 331-9530, Japan.
Exp Eye Res. 2010 May;90(5):591-7. doi: 10.1016/j.exer.2010.02.003. Epub 2010 Feb 12.
The aim of this study is to investigate the effects of estrogen on functional changes in the retinas of streptozotocin (STZ)-induced diabetic rats by using an electroretinography. Female rats were randomly divided into four treatment groups: (1) Control (sham operation and vehicle administration); (2) STZ (sham operation and STZ administration); (3) OVX (ovariectomy and vehicle administration); and (4) OVX + STZ (ovariectomy and STZ administration). Full-field electroretinograms (ERGs) were recorded before OVX and STZ administration and 4 and 12 weeks after STZ administration. At 4 weeks after STZ administration, although there were no differences in the STZ and OVX groups compared with the Control group, the amplitude of the cone-response was significantly lower in the OVX + STZ group than in the Control group (P = 0.013). At 12 weeks after STZ administration, this response showed a similar tendency in the STZ and the OVX + STZ groups. At 12 weeks after STZ administration, the implicit times of OP3 and OP4 and of the cone-response were significantly delayed in the STZ and OVX + STZ groups (OP3: P = 0.030 and 0.050, OP4: P = 0.0060 and 0.0053, cone-response: P = 0.014 and 0.039), compared with in the Control group. Thus, the retinal functions in STZ-induced diabetic female rats were aggravated by OVX. OVX-induced estrogen deficiency resulted in earlier changes in the amplitudes of cone-response, especially in the diabetes, although this is a transient effect and it is difficult to explain. Recognizing the early neurosensory change would enable a better understanding of the effect of estrogen in the retina.
本研究旨在通过视网膜电流图(ERG)研究雌激素对链脲佐菌素(STZ)诱导的糖尿病大鼠视网膜功能变化的影响。雌性大鼠随机分为四组:(1)对照组(假手术和载体给药);(2)STZ 组(假手术和 STZ 给药);(3)OVX 组(卵巢切除术和载体给药);和(4)OVX+STZ 组(卵巢切除术和 STZ 给药)。在 OVX 和 STZ 给药前以及 STZ 给药后 4 周和 12 周记录全视野 ERG。STZ 给药后 4 周,与对照组相比,STZ 组和 OVX 组无差异,但 OVX+STZ 组的锥反应幅度明显低于对照组(P=0.013)。STZ 给药后 12 周,STZ 组和 OVX+STZ 组均表现出类似的趋势。STZ 给药后 12 周,OP3 和 OP4 以及锥反应的潜时在 STZ 组和 OVX+STZ 组明显延迟(OP3:P=0.030 和 0.050,OP4:P=0.0060 和 0.0053,锥反应:P=0.014 和 0.039),与对照组相比。因此,OVX 加重了 STZ 诱导的糖尿病雌性大鼠的视网膜功能障碍。OVX 诱导的雌激素缺乏导致锥反应幅度的早期变化,尤其是在糖尿病中,尽管这是一种短暂的影响,难以解释。认识到早期的神经感觉变化将有助于更好地理解雌激素对视网膜的影响。